$0.00
Tirzepatide
$299.00
9 in stock
Description
TiraZomeâ„¢ is a dual GLP-1 and GIP receptor agonist formulation modeled after next-generation incretin research. It is studied in models targeting appetite control, fat metabolism, and blood glucose regulation. As a peptide mimetic of tirzepatide, TiraZomeâ„¢ supports metabolic research in obesity, type 2 diabetes, and insulin resistance.
Quantity:
60mg per vial
Purity:
≥99% (HPLC Verified)
Format:
Lyophilized powder
Storage:
Store at -20°C, protect from light and moisture
Solvent:
Bacteriostatic Water
Concentration:
Add 1mL BAC water = 60mg/mL solution
Stability:
Store at 2°C–8°C; use within 30 days
2.5mg:
~0.042mL = ~4 units (100iu syringe)
5mg:
~0.083mL = ~8 units
10mg:
~0.167mL = ~17 units
Application:
Studied in metabolic, glycemic, and weight management models
Dosing based on 60mg/mL concentration.
Research Use:
For educational and laboratory study only
Qualified Use:
For licensed researchers and scientific professionals
Scientific Basis:
Reflects GLP-1/GIP agonist studies in metabolic optimization models
Reminder:
Do not misbrand, misuse, or misrepresent this compound
NEJM (2022):
Lancet (2021):
ClinicalTrials.gov:
Disclaimer
TiraZomeâ„¢ is provided strictly for research and reference purposes only. This compound is not approved for medical use and is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.